Safety and Immunogenicity of Novartis Meningococcal B Vaccine Formulated With OMV Manufactured at Two Different Sites, in Healthy Adolescents Aged 11-17 Years
Clinical trial NCT01423084 · COMPLETED
Trial details
- NCT number
- NCT01423084
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2011-12-01
- Enrollment
- 344
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.